Try our beta test site

First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal Cancer (FOIB)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Gruppo Oncologico del Nord-Ovest
ClinicalTrials.gov Identifier:
NCT01163396
First received: July 9, 2010
Last updated: March 10, 2015
Last verified: March 2015